Abstract
A 67-year-old man, who had received intermittent courses of oral chlorambucil and prednisone as therapy for chronic lymphocytic leukaemia over a period of 3.5 years, developed fatal lung fibrosis. A case report and brief reviewof the current data on chlorambucil-induced lung disease are presented.
Original language | English (US) |
---|---|
Pages (from-to) | 156-158 |
Number of pages | 3 |
Journal | Acta Haematologica |
Volume | 83 |
Issue number | 3 |
DOIs | |
State | Published - 1990 |
Keywords
- Chlorambucil
- Chronic lymphocytic leukaemia
- Lung fibrosis
ASJC Scopus subject areas
- Hematology